Target Name: MIR149
NCBI ID: G406941
Review Report on MIR149 Target / Biomarker Content of Review Report on MIR149 Target / Biomarker
MIR149
Other Name(s): MIRN149 | mir-149 | MicroRNA 149 | microRNA 149 | hsa-mir-149 | hsa-miR-149-3p | hsa-miR-149-5p

MIR149: A Potential Drug Target and Biomarker

MIR149 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker in various diseases, including cancer. Its unique structure and function have made it an attractive target for researchers to investigate, and several studies have suggested that MIR149 may play a crucial role in the development and progression of these diseases.

MIR149 is a part of the microRNA (miRNA) family, which is a class of non-coding RNAs that are known for their ability to interact with mRNAs and regulate their stability and translation. MIR149 is a single-stranded RNA molecule that contains 20 amino acid residues. It is expressed in various tissues and cells and is involved in the regulation of gene expression.

One of the defining features of MIR149 is its ability to interact with other molecules and molecules families. Its C-terminus contains a leucine acid loop that is able to interact with the N-terminal region of the pre-mRNA, allowing it to form a stable complex with the protein responsible for the loading of the mRNA onto the ribosome. This interaction between MIR149 and the ribosome suggests that MIR149 may play a role in the regulation of gene expression and protein synthesis.

MIR149 has also been shown to interact with other molecules that are involved in the development and progression of cancer. For example, studies have shown that MIR149 is involved in the regulation of the expression of genes that are associated with cancer cell survival and angiogenesis. Additionally , MIR149 has been shown to be involved in the regulation of cell cycle progression, which is a critical step in the development and progression of cancer.

Due to its involvement in the regulation of gene expression and protein synthesis, MIR149 has been identified as a potential drug target for cancer. Several studies have shown that MIR149 can be targeted by small molecules and antibodies, and that these treatments can inhibit its activity and reduce the growth of cancer cells. Additionally, targeting MIR149 may be a promising strategy for the development of new cancer therapies.

MIR149 has also been identified as a potential biomarker for cancer. Its expression has been shown to be elevated in various types of cancer, including breast, ovarian, and prostate cancer. Additionally, studies have shown that MIR149 can be used as a diagnostic biomarker for cancer, as its expression levels can be detected in various types of cancer and can be correlated with clinical outcomes. Therefore, MIR149 may be a valuable tool for the diagnosis and prognosis of cancer.

In conclusion, MIR149 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker in various diseases, including cancer. Its unique structure and function have made it an attractive target for researchers to investigate, and several studies have suggested that MIR149 may play a crucial role in the development and progression of these diseases. Further research is needed to fully understand the role of MIR149 in the regulation of gene expression and protein synthesis, as well as its potential as a drug target and biomarker for cancer .

Protein Name: MicroRNA 149

The "MIR149 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR149 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR150 | MIR151A | MIR151B | MIR152 | MIR153-1 | MIR153-2 | MIR1537 | MIR1538 | MIR1539 | MIR154 | MIR155 | MIR155HG | MIR1587 | MIR15A | MIR15B | MIR16-1 | MIR16-2 | MIR17 | MIR17HG | MIR181A1 | MIR181A1HG | MIR181A2 | MIR181A2HG | MIR181B1 | MIR181B2 | MIR181C | MIR181D | MIR182 | MIR1825 | MIR1827 | MIR183 | MIR184 | MIR185 | MIR186 | MIR187 | MIR188 | MIR18A | MIR18B | MIR1908 | MIR1909 | MIR190A | MIR190B | MIR191 | MIR1910 | MIR1911 | MIR1912 | MIR1913 | MIR1914 | MIR1915 | MIR1915HG | MIR192 | MIR193A | MIR193B | MIR193BHG | MIR194-1 | MIR194-2 | MIR194-2HG | MIR195 | MIR196A1 | MIR196A2 | MIR196B | MIR197 | MIR1972-1 | MIR1972-2 | MIR1973 | MIR1976 | MIR198 | MIR199A1 | MIR199A2 | MIR199B | MIR19A | MIR19B1 | MIR19B2 | MIR200A | MIR200B | MIR200C | MIR200CHG | MIR202 | MIR202HG | MIR203A | MIR203B | MIR204 | MIR205 | MIR2052 | MIR2052HG | MIR2053 | MIR2054 | MIR205HG | MIR206 | MIR208A | MIR208B | MIR20A | MIR20B | MIR21 | MIR210 | MIR210HG | MIR211 | MIR2110 | MIR2113 | MIR2114